Navigation Links
New Data Showed Minimal Potential for Drug Interaction Between Cholesterol Drug LIVALO® and a Common Antiretroviral Therapy
Date:7/18/2011

actual future experience and results to differ materially from the statements made. Factors that might cause such a difference include, among others, Lilly and Kowa abilities to successfully commercialize and market LIVALO, competition from other pharmaceutical companies (including generic versions of other statin products), potential regulatory developments affecting the product, and other factors described in Lilly's most recent filings with the Securities and Exchange Commission. For additional information about the factors that affect the company's business, please see Lilly's latest Form 10-K, filed February 2009, and Form 10-Q filed October 2009. Lilly undertakes no duty to update forward-looking statements.

LIVALO is a registered trademark of the Kowa group of companies.

PS72893 LIV-MT-124


'/>"/>
SOURCE Kowa Pharmaceuticals America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
2. One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function
3. New Study of Concerta(R) Showed Significant Improvement of ADHD Symptom Management in Adults Compared to Placebo
4. CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
5. New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
6. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
7. New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
8. Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight
9. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
10. Top-Line Results of Boceprevir Phase II Study Showed High Rate of Sustained Response (SVR) in Genotype 1 Treatment-Naive Hepatitis C Patients
11. Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ... and audio webcast to discuss financial results for the second ... July 31, 2014 at 4:30 p.m. ET. ... July 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the ...
(Date:7/28/2014)... SAN FRANCISCO , July 28, 2014 /PRNewswire/ ... that it has received the Get With The ... quality improvement measures outlined by the American Heart ... patients. Stroke is the number four cause of ... in the United States , ...
(Date:7/28/2014)... Calif., July 28, 2014 Anthera Pharmaceuticals, Inc. (NASDAQ: ... update for the second quarter ended June 30, 2014. ... 30, 2014 was $7.3 million, compared to $8.3 million for ... is a direct result of a decrease in interest expense ... the six months ended June 30, 2014 was $15.2 million, ...
Breaking Medicine Technology:Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 5Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 6Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 7
... Mass., Aug. 26, 2011 - Vention Medical, ... announced today its acquisition of ANSAmed, Ireland,s ... including multilayer, co-extrusion and multi-lumen extrusion capabilities, ... The acquisition of ANSAmed will ...
... Md., Aug. 26, 2011 The FDA reminds consumers ... safety of their food and medical supplies for themselves ... hurricane-related rain, possible flooding and power outages. ... also reminds consumers that it is important to have ...
Cached Medicine Technology:Vention Medical Acquires ANSAmed 2FDA Hurricane Preparedness Checklist 2FDA Hurricane Preparedness Checklist 3FDA Hurricane Preparedness Checklist 4
(Date:7/28/2014)... Two beneficial variants of a gene controlling red blood ... human populations across the globe, according to a new ... studied the genomes of world populations to look for ... which stimulate fetal haemoglobin production into adulthood. Fetal haemoglobin ... patients with inherited blood disorders who are able to ...
(Date:7/28/2014)... VA (PRWEB) July 29, 2014 A ... the Social Security disability trust fund by reallocating payroll ... a new poll by The Senior Citizens League ... polled said shifting revenues from the Social Security retirement ... way to fix the disability program’s financing. “TSCL believes ...
(Date:7/28/2014)... NAPW honors Pamela A. ... as a 2014 Professional Woman of the Year. Ms. ... in community health. As the largest, most-recognized networking organization ... and profession, the National Association of Professional Women (NAPW) ... members and nearly 300 Local Chapters. , In her ...
(Date:7/28/2014)... have long known that they monopolize large amounts of ... cells are also characterized by a series of features ... ordered set. Researchers are calling this behavior "mesenchymal," and ... Meylan,s research team was able to demonstrate that the ... result from the same mechanism, at least in ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Evolve Medical Clinics ... 2014, offering its members virtual visits and dramatic operational changes ... , Some estimates state that as many as 70% of ... “Imagine not having to leave your office or home for ... blood pressure or cholesterol,” CEO and Founder Michael R. Freedman, ...
Breaking Medicine News(10 mins):Health News:Study tracks worldwide spread of beneficial blood cell gene variant 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 3Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 2Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 3Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2Health News:Cancer: Tumors absorb sugar for mobility 2Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 2Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 3Health News:Evolve Medical Clinics to Open First Next Generation Primary and Urgent Care Facility 4
... a precarious time, as about 15 percent of women ... risk increases when pregnant women undergo surgery, which is ... instituted a same-day pregnancy testing protocol. A study published ... shows that this protocol is effective in identifying ...
... Will Expand Product Line and International ... ... PSS Systems, the leader,in legal holds and retention management solutions, announced ... existing,investors, including Lightspeed Venture Partners, Azure Capital, Granite,Ventures, and Cipio Partners, ...
... higher rate of impairment among diabetics , , MONDAY, June ... common, under-recognized complication of diabetes, suggests a U.S. study. ... common in people with diabetes than people without the ... to be caused by other factors such as exposure ...
... emotional and,energetic performances, Garth Brooks, Jon McLaughlin, and ... Foundation, a world leader in,promoting hearing health awareness, ... World May Hear" Awards Gala, held Saturday, June ... money raised at the Gala, the Starkey,Hearing Foundation ...
... Metropolitan Health Plan (MHP(R)),the HMO of Hennepin County, ... Chief Financial Officer and David R. Johnson,Executive Director., ... County for over 35,years. During his tenure at MHP, ... Medical Assistance, to a plan that offers 10 government,sponsored ...
... - Two years ago researchers at the University of ... TDP-43 accumulated in the motor areas of the brains ... Gehrig,s disease. Now, the same group has shown that ... neurological effects than previously appreciated and treatments need to ...
Cached Medicine News:Health News:Same-day pregnancy test provides valuable guidance to pre-surgery patients 2Health News:PSS Systems Secures $18 Million in Financing 2Health News:PSS Systems Secures $18 Million in Financing 3Health News:PSS Systems Secures $18 Million in Financing 4Health News:Diabetes Might Help Spur Hearing Loss 2Health News:Garth Brooks, Jon McLaughlin, and Pat Benatar and Neil Giraldo Raise Their Voices to Help Starkey Hearing Foundation Raise More Than $5 Million at Annual Fundraiser 2Health News:Metropolitan Health Plan Announces Senior Management Appointments 2Health News:Lou Gehrig's protein found throughout brain, suggesting effects beyond motor neurons 2
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
... Tip Guidewire has a flexible, radiopaque ... tip. The longitudinal distal/proximal movement of ... proximal end of the guidewire, deflects ... Guidewire length, diameter, and distal tip ...
The 3-chip MediLive Trio Eye video camera is built to adapt to changing conditions during ophthalmic surgery with features designed for workflow optimization and maximum image quality....
... GPA software accurately differentiates clinically significant ... random variability, providing an advanced, proven ... for your patients. , ,The software ... clinical trial, in which the actual ...
Medicine Products: